首页 | 本学科首页   官方微博 | 高级检索  
检索        

力克肺疾丁胺卡那治疗耐多药肺结核疗效分析
引用本文:商明群.力克肺疾丁胺卡那治疗耐多药肺结核疗效分析[J].医药论坛杂志,2004,25(13):21-22.
作者姓名:商明群
作者单位:江苏省盐城市第二人民医院肺科,盐城市,224003
摘    要:目的 评价力克肺疾片联合丁胺卡那霉素治疗耐药物性肺结核的临床疗效及不良反应。方法 选取耐多药肺结核患者 135例 ,治疗组 70例采用 3DKOThE/ 9DOThE方案 ,对照组 6 5例采用 3KOThE/ 9OThE方案。结果 治疗 12个月后 ,治疗组痰菌阴转率 ,病灶吸收好转率明显高于对照组 (P <0 .0 5 )。结论 含力克肺疾片方案优于对照组 ,适用于耐多药肺结核的治疗。

关 键 词:力克肺疾  肺结核  耐药
文章编号:1672-3422(2004)13-0021-02
修稿时间:2004年4月16日

Therapeutic Effects of Dipasic Combining with Amikacin on Multi- drug Resistant Pulmonary Tuberculosis
SHANG Mingqun.Therapeutic Effects of Dipasic Combining with Amikacin on Multi- drug Resistant Pulmonary Tuberculosis[J].Journal of Medical Forum,2004,25(13):21-22.
Authors:SHANG Mingqun
Institution:SHANG Mingqun The Second Hospital of Yancheng City,Yancheng 224003,China
Abstract:Objective To evaluate the effect and safety of Dipasic on multi-drug resistant pulmonary tuberculosis. Methods 135 cases of multi-drug resistant tuberculosis,70 cases of therapeutic group were treated with 3DKOThE/9DOThE project,65 cases of control group were treated with3KOThE/9OThE project. Results After 12 months of treatment,the conversion rates of sputum and foci absorption rate in the therapeutic group were much higher than those of the control group(P<0.05). Conclusion The project with Dipasic superior to the control group,it is effective for treating the multi-drug resistant pulmonary tuberculosis.
Keywords:Dipasic  Pulmonary tuberculosis  Drug resistant
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号